PX'Therapeutics Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 29

Employees

  • Latest Deal Type
  • M&A

PX'Therapeutics General Information

Description

Developer of a biotechnology company designed to support the development of biotherapeutics. The company provides contract research, process development, and manufacturing services for recombinant proteins and monoclonal antibodies, enabling pharmaceutical and biotechnology firms to advance therapeutic candidates from early-stage research through to clinical and commercial production.

Contact Information

Formerly Known As
Protein'eXpert
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 7, parvis Louis Néel MINATEC - BHT 52 A
  • Cedex 9, CS 20050
  • 38040 Grenoble
  • France
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Acquirer
Aguettant Sante
Corporate Office
  • 7, parvis Louis Néel MINATEC - BHT 52 A
  • Cedex 9, CS 20050
  • 38040 Grenoble
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PX'Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 03-Oct-2012 Completed Generating Revenue
3. Secondary Transaction - Private 06-Feb-2008 Completed Generating Revenue
2. Grant 19-Nov-2003 $1.52M Completed Startup
1. Seed Round 19-Nov-2003 $1.52M $1.52M Completed Startup
To view PX'Therapeutics’s complete valuation and funding history, request access »

PX'Therapeutics Patents

PX'Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-2864549-B1 Molecular engineering method for optimizing the expression of recombinant proteins at high and low rate. Inactive 31-Dec-2003
FR-2864549-A1 Preparation of recombinant proteins at different rates in different cells, useful e.g. for making therapeutic antibodies, based on operational integration of dna cassettes Active 31-Dec-2003

PX'Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PX'Therapeutics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amorcage Rhone-Alpes Venture Capital Minority
Crédit Mutuel Equity Growth/Expansion Minority
Kreaxi Venture Capital Minority
Rhône Dauphiné Développement Venture Capital Minority
Rhône-Alpes Création Venture Capital Minority
To view PX'Therapeutics’s complete investors history, request access »

PX'Therapeutics FAQs

  • When was PX'Therapeutics founded?

    PX'Therapeutics was founded in 2000.

  • Where is PX'Therapeutics headquartered?

    PX'Therapeutics is headquartered in Grenoble, France.

  • What is the size of PX'Therapeutics?

    PX'Therapeutics has 29 total employees.

  • What industry is PX'Therapeutics in?

    PX'Therapeutics’s primary industry is Biotechnology.

  • Is PX'Therapeutics a private or public company?

    PX'Therapeutics is a Private company.

  • What is PX'Therapeutics’s current revenue?

    The current revenue for PX'Therapeutics is .

  • How much funding has PX'Therapeutics raised over time?

    PX'Therapeutics has raised $1.52M.

  • Who are PX'Therapeutics’s investors?

    Amorcage Rhone-Alpes, Crédit Mutuel Equity, Kreaxi, Rhône Dauphiné Développement, and Rhône-Alpes Création have invested in PX'Therapeutics.

  • When was PX'Therapeutics acquired?

    PX'Therapeutics was acquired on 03-Oct-2012.

  • Who acquired PX'Therapeutics?

    PX'Therapeutics was acquired by Aguettant Sante.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process